Drug regulators strive to tackle AI challenge
China Daily· 33 分鐘前Xu Jinghe, deputy commissioner of the National Medical Products Administration, said that technological ...
Immunity gained from COVID can last as long as 2 years
China Daily· 1 小時前The research, published by the medical journal The Lancet Microbe ...
Eli Lilly vs. Novo Nordisk: The pros deliver their verdict on the viral weight-loss stocks ...
CNBC· 3 小時前It has been quite a year for both Eli Lilly and Novo Nordisk given the boom in weight-loss ... ...
CNBC Daily Open: Of billions and trillions
CNBC· 3 小時前This report is from today's CNBC Daily Open, our new, international markets newsletter. ...
*CMS Trims WUXI BIO (02269.HK) TP to $45; Weak Innovative Drug Financing, Lagging Customer Plan ...
AASTOCKS.com· 5 小時前... (including, without limitation, any warranty or merchantability or fitness for a particula ...
Eli Lilly obesity drug now available in US pharmacies
Reuters· 7 小時前Eli Lilly (LLY.N) on Tuesday said its recently approved obesity treatment Zepbound is now ...
CVS sees upbeat 2024 revenue, plans to simplify drug pricing process
Reuters· 7 小時前Health (CVS.N) on Tuesday forecast 2024 revenue above market estimates and said it ...
Danaher's new acquisition is the latest sign the health-care firm is staging a quiet recove ...
CNBC· 8 小時前a recovery at its bioprocessing business. Danaher's recent stock-price recovery was helped last week ...
Altimmune open to partnerships, deals with drugmakers, says CEO
Reuters· 8 小時前Upbeat mid-stage trial data for its obesity drug and recent multi-billion dollar deals by companies such ...
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages ...
CNBC· 9 小時前Eli Lilly on Tuesday said its recently approved weight loss treatment Zepbound is now available at pharmacies ...
